⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
REX Shares Launches REX Peptide ETF (PEPT)
businesswire.com
LLY
NVO
Ablexis Announce License Agreement with Novo
accessnewswire.com
NVO
Australia Drug Delivery Devices Market Size and Forecast to 2035 - Analysis by Product, Application, and End-user | Smart Devices and Home Care Drive 14% CAGR to USD 11.25 Billion
globenewswire.com
BDX
NVS
GSK
TEVA
ABBV
NVO
JNJ
SNY
VTRS
PFE
Novo Nordisk A/S - share repurchase programme
globenewswire.com
NVO
GLP-1 Drugs Market to Reach USD 132.79 Billion by 2035 as Oral Therapies, Tirzepatide and Obesity Applications Reshape Competition
globenewswire.com
NVO
LLY
BCRX
Acute Myocardial Infarction (AMI) - Market Insights, Epidemiology, and Market Forecast Now Available; Acute Myocardial Infarction (AMI) Market Projected to Reach Approximately USD 6.00 Billion by 2036
globenewswire.com
AMGN
MRK
REGN
AZN
PFE
BMY
JNJ
VTRS
CELC
NVO
ARWR
Microbiome Labs Unveils Enhanced Online Ordering Experience and Rebrand Shaped by Practitioner and Customer Feedback Ready to Announce with Confidence?
newsfilecorp.com
NVO
Novo Nordisk A/S – Share repurchase programme
globenewswire.com
NVO
Novo provides update on the denecimig Biologics License Application (BLA) in the US
globenewswire.com
NVO
PM360 2026 Trailblazer Awards Winners Announced: Top Companies, Marketers, CEOs, Products, and Initiatives Honored at Gala, Sept. 29th
prnewswire.com
ABT
AZN
CYTK
ARDX
LLY
REGN
NVO
KURA
NOV
BMY
MRK
ARGX
BMRN
TAK
VRTX
GSK
APMD
GKOS
GEN
LAR
ABBV
INCY
GILD
MOD
IQV
PFE
ALGN
SCL